Adrenal Involvement in Antiphospholipid Syndrome – ARP Rheumatology
ARP Rheumatology shared a post on LinkedIn:
“Adrenal involvement in antiphospholipid syndrome (APS) is rare but potentially fatal.
This case-based review highlights that APS-related adrenal failure may present atypically, leading to diagnostic delay – particularly in men. Awareness of this manifestation is essential, as early diagnosis and prompt initiation of anticoagulation and hormonal replacement significantly improve outcomes.
Key message: APS should be considered in patients with new-onset primary adrenal insufficiency, and adrenal involvement should be systematically evaluated in APS patients with compatible symptoms”
Title: Adrenal failure as an antiphospholipid syndrome manifestation: case-based review
Authors: Mariana Emília Santos, Catarina Gama, Bernardo Marques, Tiago Saldanha, Joana Tremoceiro, Maria Helena Lourenço, Maria João Gonçalves, Manuela Costa, Alexandre Sepriano
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 2, 2026, 08:25FIGO Committee Explores How AI and IoT Could Transform Maternity Care – IJGO
-
May 2, 2026, 08:09Cancer Therapy and Reproductive Health in Childhood Cancer Survivors – Fertility and Sterility
-
May 1, 2026, 17:39RCOG Welcomes New Tobacco Law as Step Toward a Smokefree Generation
-
May 1, 2026, 17:29Major Breakthrough in Treatment of Infertility in Patients With PCOS – Saint Joseph Hospital
-
May 1, 2026, 17:20Abnormal Embryos That Might Not Be So Abnormal After All – Fertility Plus
-
May 1, 2026, 17:13May is Women’s Health Month – ESGO
-
May 1, 2026, 17:10One Million More Midwives Needed to Improve Reproductive Care – Maternity and Midwifery Forum
-
May 1, 2026, 17:04Fertility 2027 Opens Registration With Early Bird Rates – Fertility Conferences
-
May 1, 2026, 16:58RCOG Launches Three-Day Online Event on Preterm Birth, Fetal Anomalies and Fetal Therapy